Docket Room.
HR 7953·Federal·house

FAIR ACT

In CommitteeFiled Mar 17, 2026
Sponsor: Rep. Sessions, Pete [R-TX-17] (R)
Latest Action

Referred to the House Committee on Energy and Commerce.

Mar 17, 2026

Email me when HR 7953 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HR 7953. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The FAIR Act lets the FDA grant marketing approval to a drug that is already authorized by a trusted foreign regulator when the drug is intended for an immediately life‑threatening condition. It also allows manufacturers to start U.S. clinical trials using the same foreign approvals, with the Secretary of HHS required to decide on each request within 30 days. The law adds reporting, labeling, post‑market study, withdrawal, and fee rules to protect safety.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HR 7953

3 free questions a day, no account

History

  1. Referred to the House Committee on Energy and Commerce.
  2. Introduced in House

Sponsors

  • Rep. Sessions, Pete [R-TX-17] (R) · sponsor
  • Rep. Moulton, Seth [D-MA-6] (D)
  • Rep. Peters, Scott H. [D-CA-50] (D)

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HR 7953 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HR 7953 free

Or ask your AI assistant about HR 7953 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice